Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Neutrophil-to-lymphocyte ratio, platelet-to- lymphocyte ratio and mean platelet volume in lupus nephritis (CROSBI ID 719389)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Knežević, Tamara ; Padjen, Ivan ; Bulimbašić, Stela ; Ćorić, Marijana ; Ivković, Vanja ; Laganović, Mario ; Anić, Branimir Neutrophil-to-lymphocyte ratio, platelet-to- lymphocyte ratio and mean platelet volume in lupus nephritis // Annals of rheumatic diseases. 2021. str. 1199-1199 doi: 10.1136/annrheumdis-2021-eular.4164

Podaci o odgovornosti

Knežević, Tamara ; Padjen, Ivan ; Bulimbašić, Stela ; Ćorić, Marijana ; Ivković, Vanja ; Laganović, Mario ; Anić, Branimir

engleski

Neutrophil-to-lymphocyte ratio, platelet-to- lymphocyte ratio and mean platelet volume in lupus nephritis

Background: A number of blood count parameters are associated with inflammatory and autoimmune diseases. There is discordant evidence whether neutrophil-to-lymphocyte ratio (NLR), platelet-to- lymphocyte ratio (PLR) and mean platelet volume (MPV) might reflect inflammatory response and have prognostic value in SLE patients. However, the studies examining the potential role of these markers in LN are missing. Objectives: To examine NLR, PLR and MPV at the time of biopsy in patients with LN and evaluate their association with prognosis. Methods: In this retrospective study we analyzed the demographic, histologic, laboratory and clinical characteristics of patients with biopsy- proven LN diagnosed between 2011 and 2020. All patients met the 1997 revised American College of Rheumatology classification criteria for SLE. Complete remission was defined as proteinuria <0.5 g/day and serum creatinine within 10% from baseline, and partial remission as more than 50% reduction in proteinuria to sub-nephrotic levels and serum creatinine within 10% from baseline. Results: We have included 55 patients (80% women) with biopsy-proven LN (age at biopsy 38±13 years). On renal histology, one patient was class I LN, two patients were class II, 7 were class III, 5 were class III+V, 23 were class IV, two were class IV+V, 11 class VI and 4 had other features. Median baseline NLR was 3.64 (IQR: 1.85, 6.93), PLR was 167 (IQR: 116, 300) and MPV was 10.0 (IQR: 9.2, 10.8). There were no differences in any of the three parameters between different classess of LN (all p>0.05). Eighteen patients achieved complete remission (CR), 16 partial remission and 21 did not achieve remission. None progressed to ESRD and two patients died, both from sepsis. There no differences in NLR, PLR and MPV at the time of biopsy between group which achieved CR/PR vs. no remission (all p>0.05 ; Figure 1 ). We constructed a thorough multivariate regression model which showed that neither NLR, PLR or MPV are predictors of renal remission in LN. Conclusion: NLR, PLR and MPV are not useful prognostic markers in predicting renal remission in LN.

lupus nephritis ; systemic lupus erythematosus ; complete blood cell count

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

1199-1199.

2021.

nije evidentirano

objavljeno

10.1136/annrheumdis-2021-eular.4164

Podaci o matičnoj publikaciji

Annals of rheumatic diseases

0003-4967

1468-2060

Podaci o skupu

European congress of rheumatolog (EULAR 2021)

ostalo

02.06.2021-05.06.2021

online

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost